Regulations.gov document
Drug-Induced Liver Injury: Premarketing Clinical Evaluation; Guidance for Industry
Other · FDA-2008-D-0128 · posted Jul 29, 2009
Key facts
| Document ID | FDA-2008-D-0128-0005 |
|---|---|
| Title | Drug-Induced Liver Injury: Premarketing Clinical Evaluation; Guidance for Industry |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2008-D-0128 |
| Posted | Jul 29, 2009 |
| Comment period opens | Jul 29, 2009 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: